Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
IGG INC
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 799)
SHARE PURCHASE PURSUANT TO SHARE AWARD SCHEME
References are made to the announcement of IGG Inc (the "Company") dated 24 December 2013 in respect of the Company's adoption of a share award scheme (the "Scheme") and the announcement of the Company dated 6 May 2021, in relation to the grant of Awarded Shares pursuant to the Scheme (collectively, the "Announcements"). Unless otherwise defined herein, capitalized terms used herein shall have the same meanings as ascribed to them in the Announcements.
The Company was informed by the Trustee that it had purchased an aggregate of 3,167,000 Shares ("Shares Purchased") on the market for the purpose of the Scheme. Details of Shares Purchased and the latest information about the Shares held by the Trustee are as follows:
Trade date: | 15 April 2021 to 14 May 2021 |
Settlement date: | 19 April 2021 to 18 May 2021 |
Total number of Shares Purchased: | 3,167,000 Shares |
Percentage of the Shares Purchased to | Approximately 0.27% |
the total number of issued share capital | |
of the Company as at the date of this | |
announcement: | |
Average consideration per Share: | Approximately HK$12.2353 |
Total consideration: | HK$38,749,176.65 |
1
Balance of number of Shares held by the Trustee: | ||
- prior to the purchase | 23,894,465 | Shares |
- immediately after the purchase | 26,065,236 | Shares* |
- Due to the vesting schedule, 996,229 Shares had been transferred to relevant grantees in April and May 2021.
By order of the Board
IGG INC
Zongjian Cai
Chairman
Hong Kong, 14 May 2021
As at the date of this announcement, the Board comprises five executive Directors, namely, Mr. Zongjian Cai, Mr. Yuan Xu, Mr. Hong Zhang, Ms. Jessie Shen and Mr. Feng Chen; one non- executive Director, namely, Mr. Yuan Chi; and three independent non-executive Directors, namely, Dr. Horn Kee Leong, Mr. Dajian Yu and Ms. Zhao Lu.
2